Skip to main content

Table 4 Cox regression analyses of patient OS and DFS

From: Analysis of bowel function, urogenital function, and long-term follow-up outcomes associated with robotic and laparoscopic sphincter-preserving surgical approaches to total mesorectal excision in low rectal cancer: a retrospective cohort study

Univariate and multivariate Cox regression analysis of predictors of OS and DFS

Variables

Overall survival

Disease-free survival

Univariate analysis

Multivariate analysis

Univariate analysis

Multivariate analysis

HR (95% CI)

P

HR (95% CI)

P

HR (95% CI)

P

HR (95% CI)

P

Surgical approach: robotic surgery vs laparoscopic surgery

1.016 (0.654–1.579)

0.943

NA

NA

0.979 (0.668-1.434)

0.914

NA

NA

Age ≥70 years

1.477 (0.932–2.340)

0.097

1.592 (1.028–2.648)

0.037

0.382 (0.911–2.098)

0.128

NA

NA

Gender: male vs female

1.117 (0.749–1.667)

0.587

NA

NA

1.252 (0.881–1.778)

0.21

1.548 (1.001–2.023)

0.05

Neoadjuvant chemoradiotherapy

1.133 (0.672–1.908)

0.639

NA

NA

1.475 (0.945–2.303)

0.087

NA

NA

Anastomotic leakage

1.717 (0.801–3.680)

0.165

NA

NA

1.557 (0.738–3.283)

0.245

NA

NA

R1 resection

3.594 (0.689–18.759)

0.129

NA

NA

3.197 (0.686–14.899)

0.139

NA

NA

Positive CRM

8.292 (1.938–35.490)

0.004

14.637 (4.547–47.123)

<0.0001

6.274 (1.641–23.994)

0.007

10.416 (3.261–33.266)

<0.0001

T stage: pT1-3 vs pT4a

2.111 (1.425–3.128)

<0.0001

1.884 (1.327–2.674)

0.001

1.574 (1.131–2.191)

0.007

1.515 (1.136–2.019)

0.005

N stage: pN0 vs pN+

1.521 (1.357–1.705)

<0.0001

1.534 (1.387–1.697)

<0.0001

1.382 (1.251–1.527)

<0.0001

1.411 (1.287–1.548)

<0.0001

Postoperative adjuvant chemotherapy

1.877 (0.878–4.015)

0.104

NA

NA

1.203 (0.610–2.372)

0.593

NA

NA

Postoperative adjuvant radiotherapy

0.843 (0.546–1.300)

0.439

NA

NA

0.751 (0.514–1.098)

0.139

NA

NA

  1. HR hazards ratio, CI confidence interval; an HR<1 is a positive survival predictor; otherwise, it is a negative predictor